Vireo Growth (VREOF) Tax Provisions (2020 - 2026)
Vireo Growth's (VREOF) quarterly Tax Provisions came in at $18.3 million in Q1 2026, up 976.47% year-on-year from $1.7 million in Q1 2025, and down 15.8% quarter-over-quarter from $21.7 million in Q4 2025.
Vireo Growth (VREOF) Tax Provisions (2020 - 2026) Analysis & Trends
Vireo Growth has disclosed Tax Provisions across 7 years of filings, most recently posting $18.3 million for Q1 2026.
- Tax Provisions for Q1 2026 came in at $18.3 million, up 976.47% year-over-year; the trailing twelve-month figure through Mar 2026 was $58.2 million (up 556.68% YoY), and the FY2025 annual result was $41.6 million, up 274.42% from the prior year.
- Tax Provisions came in at $18.3 million for Q1 2026 at Vireo Growth, down from $21.7 million in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $21.7 million in Q4 2025 to a low of -$7.4 million in Q4 2023.
- The 5-year median for Tax Provisions is $1.8 million (2022), against an average of $4.2 million.
- Across the five-year window, Tax Provisions tumbled 272.94% in 2022 and surged 1003.18% in 2025, its largest moves.
- Vireo Growth's Tax Provisions stood at -$4.0 million in 2022, then sank by 86.05% to -$7.4 million in 2023, then jumped by 158.43% to $4.3 million in 2024, then soared by 400.41% to $21.7 million in 2025, then decreased by 15.8% to $18.3 million in 2026.
- The last three Tax Provisions figures came in at $18.3 million (Q1 2026), $21.7 million (Q4 2025), and $13.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 67.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 157.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 43.40 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -3.57 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 48.90 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 30.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 4.60 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -9.44 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 37.99 Mn |
| 10 | Vireo Growth | - | - | 59.30 Mn | 18.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.30 Mn |
| Dec 31, 2025 | 21.73 Mn |
| Sep 30, 2025 | 13.35 Mn |
| Jun 30, 2025 | 4.85 Mn |
| Mar 31, 2025 | 1.70 Mn |
| Dec 31, 2024 | 4.34 Mn |
| Sep 30, 2024 | 2.39 Mn |
| Jun 30, 2024 | 440,000.00 |
| Mar 31, 2024 | 3.95 Mn |
| Dec 31, 2023 | -7.43 Mn |
| Sep 30, 2023 | 3.98 Mn |
| Jun 30, 2023 | 1.65 Mn |
| Mar 31, 2023 | 1.73 Mn |
| Dec 31, 2022 | -4.00 Mn |
| Sep 30, 2022 | 1.79 Mn |
| Jun 30, 2022 | 965,000.00 |
| Mar 31, 2022 | 1.38 Mn |
| Dec 31, 2021 | 2.31 Mn |
| Sep 30, 2021 | 530,000.00 |
| Jun 30, 2021 | 885,000.00 |